Company
Crispr Therapeutics
Rapidly translating a revolutionary technology into therapies
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Zug, Switzerland
- Founded
- 2013
- crisprtx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At CRISPR Therapeutics, our aim is to find cures for people suffering from serious diseases through transformative gene-based medicines.
Funding snapshot
- Total raised
- $36MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $1M2020-03-11
Funding rounds
- Round, 2020
- $1M2020-03-11, SEC form D sold, 1 investor
- Round, 2016
- $35M2016-10-20, SEC form D sold, 1 investor
Products
- Other
- CASGEVY™ (exagamglogene autotemcel)
Loading relationship preview